RINL Inhibitors
Chemical inhibitors of RINL play a crucial role in studying its function in vesicular trafficking by selectively disrupting specific signaling pathways and cellular processes. Wortmannin and LY294002 are prime examples, as they target the phosphoinositide 3-kinase (PI3K) pathway, a key regulator of vesicular trafficking. By inhibiting PI3K, these chemicals prevent the activation of AKT, a downstream effector necessary for the proper function of RINL in vesicular transport. Moreover, Go6976, by inhibiting protein kinase C, can disrupt membrane trafficking processes that are essential for RINL's role in vesicle formation and movement. Similarly, Brefeldin A's mechanism of inhibiting ADP-ribosylation factor (ARF) indirectly affects RINL's participation in vesicle formation, since ARF is crucial for vesicle budding from the Golgi apparatus.
Dynasore, by targeting dynamin, a GTPase involved in vesicle scission, hampers the endocytosis and vesicular transport processes where RINL is involved. Phenylarsine oxide (PAO), on the other hand, inhibits tyrosine phosphatases, which are important for the phosphorylation status of proteins involved in vesicular transport, thus affecting RINL's functional role. In the actin cytoskeleton dynamics, ML141, an inhibitor of Cdc42, and NSC 23766, an inhibitor of Rac1, both disrupt the formation and remodeling of actin filaments, which are critical for RINL-mediated vesicle transport. Similarly, CK-666 can inhibit the Arp2/3 complex, leading to disruption of actin polymerization and consequently impairing RINL's function. Furthermore, SMIFH2 inhibits formins, affecting the formation of long actin filaments and, thus, impacting RINL's role in vesicular transport. Lastly, Pitstop 2 and SecinH3 disrupt clathrin-mediated endocytosis and ARF GTPase exchange factors, respectively, which are vital to the vesicular trafficking processes involving RINL, highlighting the complex interplay of these inhibitors on RINL's role in cellular transport mechanisms.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent phosphoinositide 3-kinase inhibitor. By inhibiting PI3K, it prevents the downstream activation of AKT, which could be critical for RINL function as RINL is involved in vesicular trafficking regulated by PI3K-AKT signaling. Thus, wortmannin could inhibit RINL by disrupting this pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another inhibitor of phosphoinositide 3-kinases. It blocks the PI3K-dependent activation of AKT, which is necessary for many vesicular trafficking processes. RINL, known to be involved in vesicular transport, would be functionally inhibited through this blockade. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Go6976 is a protein kinase C inhibitor. Since protein kinase C plays a role in membrane trafficking and RINL is associated with vesicular transport, inhibiting PKC could impair the function of RINL by disrupting its associated signaling pathways. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts vesicle formation by inhibiting ADP-ribosylation factor (ARF), a small GTPase involved in vesicle budding from the Golgi. Since RINL is implicated in vesicular transport, the inhibition of ARF would indirectly inhibit RINL's functional role in vesicle formation. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a GTPase inhibitor that specifically targets dynamin, preventing vesicle scission from the membrane. As RINL is involved in vesicular trafficking, inhibiting dynamin function would also inhibit the functional role of RINL in endocytosis and vesicular transport. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a selective inhibitor of Cdc42, a member of the Rho family of GTPases. Cdc42 is involved in actin polymerization and vesicle trafficking, and since RINL is associated with vesicular trafficking, inhibition of Cdc42 would inhibit RINL activity by disrupting cytoskeletal dynamics. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
SecinH3 inhibits cytohesins, which are ARF GTPase exchange factors. By inhibiting cytohesins, SecinH3 would disrupt the ARF-mediated vesicular trafficking, thereby inhibiting RINL's role in vesicular transport since RINL is involved in these pathways. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 is an inhibitor of clathrin-mediated endocytosis. It prevents the formation of clathrin-coated pits, thus inhibiting the endocytosis process. As RINL is involved in vesicular trafficking, Pitstop 2 would functionally inhibit RINL by blocking a key step in clathrin-mediated transport. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
CK-666 is an inhibitor of the Arp2/3 complex, which is involved in the nucleation of new actin filaments. Inhibition of Arp2/3 complex would disrupt actin dynamics necessary for vesicular transport, thereby inhibiting RINL's role in this process. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC 23766 inhibits Rac1, which is part of the Rho family of GTPases and is involved in actin polymerization. Given that RINL is associated with vesicular trafficking, inhibiting Rac1 would disrupt the actin cytoskeleton dynamics and vesicle transport, thereby functionally inhibiting RINL. | ||||||